v3.26.3
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
Series A Convertible
Preferred Stock
Common Stock
Additional Paid-In- Capital
Accumulated Deficit
Other Comprehensive Income (Loss)
Total
Balance at Dec. 31, 2024 $ 181 $ 200,671,122 $ (217,830,518) $ 134,391 $ (17,024,824)
Balance (in Shares) at Dec. 31, 2024 1,810,140        
Common stock issued upon draw on the equity line of credit $ 2 836,765 836,767
Common stock issued upon draw on the equity line of credit (in Shares) 17,900        
Common stock issued for services rendered $ 1 183,000 183,000
Common stock issued for services rendered (in Shares) 5,000        
Stock based compensation 759,123 759,123
Common stock issued upon vesting of RSUs 1 1
Common stock issued upon vesting of RSUs (in Shares) 4,573        
Common stock issued as compensation for equity line of credit commitment fee 25,000 25,000
Common stock issued as compensation for equity line of credit commitment fee (in Shares) 1,375        
Settlement of convertible note agreement for shares issued 700,000 700,000
Settlement of convertible note agreement for shares issued (in Shares) 4,667        
Foreign currency translation adjustment 224,092 224,092
Net income (loss) (1,736,512) (1,736,512)
Common stock issued in connection with public offering, net of equity issuance costs $ 46 4,937,456 4,937,502
Common stock issued in connection with public offering, net of equity issuance costs (in Shares) 459,455        
Common stock issued upon exercise of stock options 18 18
Common stock issued upon exercise of stock options (in Shares) 1,640        
Common stock issued as consideration for Crowdkeep $ 20 6,830,337 6,830,358
Common Stock Issued As Consideration For Crowdkeep (In Shares) 203,284        
Balance at Sep. 30, 2025 $ 250 214,942,822 (219,567,030) 358,483 (4,265,475)
Balance (in Shares) at Sep. 30, 2025 2,508,034        
Balance at Jun. 30, 2025 $ 204 209,686,147 (220,942,324) 323,384 (10,932,589)
Balance (in Shares) at Jun. 30, 2025 2,046,322        
Stock based compensation 319,211 319,211
Common stock issued upon vesting of RSUs 1 1
Common stock issued upon vesting of RSUs (in Shares) 1,530        
Foreign currency translation adjustment 35,099 35,099
Net income (loss) 1,375,294 1,375,294
Common stock issued in connection with public offering, net of equity issuance costs $ 46 4,937,456 4,937,502
Common stock issued in connection with public offering, net of equity issuance costs (in Shares) 459,455        
Common stock issued upon exercise of stock options 7 7
Common stock issued upon exercise of stock options (in Shares) 726        
Balance at Sep. 30, 2025 $ 250 214,942,822 (219,567,030) 358,483 (4,265,475)
Balance (in Shares) at Sep. 30, 2025 2,508,034        
Balance at Dec. 31, 2025 $ 252 215,990,198 (224,490,556) (1,251,774) (9,751,880)
Balance (in Shares) at Dec. 31, 2025 2,523,371        
Common stock issued upon conversion of White Lion Convertible Notes $ 91 1,432,463 1,432,554
Common stock issued upon conversion of White Lion Convertible Notes (in Shares) 914,916        
Common stock issued upon draw on the equity line of credit $ 13 99,987 100,000
Common stock issued upon draw on the equity line of credit (in Shares) 129,424        
Common stock issued for services rendered $ 4 184,547 184,551
Common stock issued for services rendered (in Shares) 31,294        
Stock based compensation 1,090,483 1,090,483
Issuance of White Lion Warrants 658,731 658,731
Settlement of related party note payable and related party liabilities for preferred stock $ 25 23,010,896 23,010,921
Settlement of related party note payable and related party liabilities for preferred stock (in Shares) 253,329        
Common stock issued upon vesting of RSUs $ 3 (3)
Common stock issued upon vesting of RSUs (in Shares) 30,000        
Common stock issued as compensation for equity line of credit commitment fee $ 1 73,022 73,023
Common stock issued as compensation for equity line of credit commitment fee (in Shares) 6,216        
Settlement of convertible note agreement for shares issued $ 9 833,370 833,379
Settlement of convertible note agreement for shares issued (in Shares) 94,569        
Common stock issued under Share Issuance Agreements $ 9 630,454 630,463
Common stock issued under Share Issuance Agreements (in Shares) 88,265        
Foreign currency translation adjustment (55,788) (55,788)
Net income (loss) (12,358,543) (12,358,543)
Balance at Sep. 30, 2026 $ 25 $ 382 244,004,148 (236,849,099) (1,307,562) 5,847,894
Balance (in Shares) at Sep. 30, 2026 253,329 3,818,055        
Balance at Jun. 30, 2026 $ 25 $ 285 242,721,440 (233,189,512) (1,481,385) 8,050,853
Balance (in Shares) at Jun. 30, 2026 253,329 2,854,338        
Common stock issued upon conversion of White Lion Convertible Notes $ 82 1,102,737 1,102,819
Common stock issued upon conversion of White Lion Convertible Notes (in Shares) 822,249        
Common stock issued upon draw on the equity line of credit $ 12 32,324 32,336
Common stock issued upon draw on the equity line of credit (in Shares) 115,174        
Common stock issued for services rendered $ 3 124,997 125,000
Common stock issued for services rendered (in Shares) 26,294        
Stock based compensation 22,650 22,650
Foreign currency translation adjustment 173,823 173,823
Net income (loss) (3,659,587) (3,659,587)
Balance at Sep. 30, 2026 $ 25 $ 382 $ 244,004,148 $ (236,849,099) $ (1,307,562) $ 5,847,894
Balance (in Shares) at Sep. 30, 2026 253,329 3,818,055